5 Things About Diabetes Drugs From The Ada Scientific Sessions | Latest News RSS feed

5 Things About Diabetes Drugs From The Ada Scientific Sessions - Latest News


Amarin Sponsors Three Scientific Presentations Scheduled for American Diabetes Association Scientific Sessions

is supporting the presentation of three accepted scientific presentations at the American Diabetes Association (ADA) Scientific Sessions in Orlando, FL, June 22-26, 2018. “This research shows that mor... read more

Novelion Therapeutics Announces Presentation of Positive Metreleptin Data at American Diabetes Association Scientific Sessions

today announced that clinical data from a metreleptin study assessing weight loss in overweight and obese adults with low leptin levels will be featured in a poster presentation at the American Diabet... read more

AstraZeneca to present scientific advances in Cardiovascular and Metabolic Diseases at 2017 ADA Scientific Sessions

“SGLT-2i is associated with lower risk of mortality and heart failure compared to other glucose lowering drugs: A three-country ... American Diabetes Association Scientific Sessions 2017. Abstract #12... read more

Looking for another news?


Eli Lilly and Co (LLY) Presents at Morgan Stanley Healthcare Conference Broker Conference (Transcript)

Question-and-Answer Session ... things that's there's been heavy emphasis is can you find complementary products that can enhance the effects of PD-1 or PD-L1s. And we think there's a good ... read more


Five diabetes myths, busted

David Kendall, M.D., is the chief scientific and medical officer of the The American Diabetes Association. The group’s 71st Scientific Sessions begin Friday in ... Knowing the facts (and your own risk ... read more

5 Risks Linked to Diabetes Medications Like Lantus, Avandia, Actos

The safety worries about these diabetes medications come from scientific studies of varying designs ... very effective drug." Sanofi-Aventis contributes funding for the ADA's professional, patient, an... read more

Researchers launch phase II trial of BCG vaccine to reverse type 1 diabetes

A phase II clinical trial testing the ability of the generic vaccine bacillus Calmette-Guérin (BCG) to reverse advanced type 1 diabetes has received approval from the U.S. Food and Drug ... Scientific ... read more

CohBar Presents Preclinical Data on Mechanism of Action for its Lead Candidate, CB4211, at American Diabetes Association 78th Scientific Sessions

its lead MBT candidate under development as a potential treatment for non-alcoholic steatohepatitis (NASH), at the American Diabetes Association (ADA) 78 th Scientific Sessions, held June 22-26, 2018 ... read more

CohBar Presents Preclinical Data on Mechanism of Action for its Lead Candidate, CB4211, at American Diabetes Association 78th Scientific Sessions

its lead MBT candidate under development as a potential treatment for non-alcoholic steatohepatitis (NASH), at the American Diabetes Association (ADA) 78 th Scientific Sessions, held June 22-26, 2018 ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us